Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Biosimilars to treat inflammatory arthritis: the challenge of proving identity.
Invasive skin carcinoma--Ras and alpha6beta4 integrin lead the way.
Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation.
Retroactive maintains cuticle integrity by promoting the trafficking of Knickkopf into the procuticle of Tribolium castaneum.
Risk-group targeted inferior vena cava filter placement in gastric bypass patients.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biosimilars to treat inflammatory arthritis: the challenge of proving identity.
Kay J, Smolen JS. Biosimilars to treat inflammatory arthritis: the challenge of proving identity. Ann Rheum Dis. 2013 Oct; 72(10):1589-93.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antirheumatic Agents
Arthritis, Rheumatoid
Female
Humans
Immunoglobulin G
Infliximab
Male
Methotrexate
Spondylitis, Ankylosing
authors with profiles
Jonathan Kay MD